Broad Effectiveness: Study With Aripiprazole

Otsuka

Status and phase: Completed; Phase 3

Conditions: Schizophrenia; Schizoaffective Disorder

Treatments: Drug: Aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00036361

CN138-087

Details and patient eligibility

About

The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Patients with Schizophrenia or Schizoaffective Disorder

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)